Anti-amyloidogenic property of leaf aqueous extract of Caesalpinia crista

Neuroscience Letters

Volumn 475, Issue 2, 2010, Pages 110-114

  Ramesh, B N ^a   Indi, S S ^b   Rao, K S J ^a  

^a CENTRAL FOOD TECHNOLOGICAL RESEARCH INSTITUTE   (India)

^b INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

A (42); Aggregation inhibition; C. crista; Thioflavin T; Transmission electron microscopy

Indexed keywords

AMYLOID BETA PROTEIN; CAESALPINIA CRISTA EXTRACT; HERBACEOUS AGENT; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; CAESALPINIA; CAESALPINIA CRISTA; DRUG DETERMINATION; DRUG ISOLATION; DRUG TARGETING; GENE TARGETING; NEUROFILAMENT; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; TRANSMISSION ELECTRON MICROSCOPY;

AMYLOID; AMYLOID BETA-PROTEIN; CAESALPINIA; MICROSCOPY, ELECTRON, TRANSMISSION; PEPTIDE FRAGMENTS; PLANT EXTRACTS; PLANT LEAVES; POLYMERS; WATER;

EID: 77952885334     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.03.062     Document Type: Article

References (44)

1. Burley S.K., Petsko G.A. Aromatic-aromatic interaction: a mechanism of protein structure stabilization. Science 1985, 229:23-28.
2. Cheenpracha S., Srisuwan R., Karalai C., Ponglimanont C., Chantrapromma S., Chantrapromma K., Hoong-Kun F., Shazia A., Atta-ur R. New diterpenoids from stems and root of C. crista. Tetrahedron 2005, 61:8656-8662.
3. Chromy B.A., Nowak R.J., Lambert M.P., Viola K.L., Chang L., Velasco P.T., Jones B.W., Fernandez S.J., Lacor P.N., Horowitz P., Fiinch C.E., Krafft G.A., Klein W.L. Self-assembly of Abeta (1-42) into globular neurotoxins. Biochemistry 2003, 42:12749-12760.
4. Dhanasekaran M., Holcomb L.A., Hitt A.R., Tharakan B., Porter J.W., Young K.A., Manyam B.V. Centella asiatica extract selectively decreases amyloid β levels in hippocampus of Alzheimer's disease animal model. Phytother. Res. 2009, 23:14-19.
5. Dhar M.L., Dhar M.M., Mehoursotra B.N., Roy C. Screening of Indian plants for biological activity. Indian J. Explor. Biol. 1968, 6:232-247.
6. Fujiwara H., Tabuchi M., Yamaguchi T., Iwasaki K., Furukawa K., Sekiguchi K., Ikarashi Y., Kudo Y., Higuchi M.C., Saido T., Maeda S., Takashima A., Hara M., Yaegashi N., Kase Y., Arai H. A traditional medicinal herb Paeonia suffruticosa and its active constituent 1,2,3,4,6-penta-o-galloyl-β-d-glucopyranose have potent anti-aggregation effects on Alzheimer's amyloid β proteins in vitro and in vivo. J. Neurochem. 2009, 109:1648-1657.
7. Fujiwara H., Iwasaki K., Furukawa K., Seki T., He M., Maruyama M., Tomita N., Kudo Y., Higuchi M., Saido T.C., Maeda S., Takashima A., Hara M., Ohizumi Y., Arai H. Uncaria rhynchophylla, a Chinese medicinal herb, has potent anti-aggregation effects on Alzheimer's beta-amyloid proteins. J. Neurosci. Res. 2006, 82:427-433.
8. Gazit E. A possible role for π- stacking in self-assembly of amyloid fibrils. FASEB J. 2002, 16:77-83.
9. Gazit E. Mechanistic studies of the process of amyloid fibrils formation by the use of peptide fragments and analogues: implications for the design of fibrillization inhibitors. Curr. Med. Chem. 2002, 9:1725-1735.
10. Gupta V.B., Rao K.S.J. Anti-amyloidogenic activity of S-allyl-l-cysteine and its activity to destabilize Alzheimer's β-amyloid fibrils in vitro. Neurosci. Lett. 2007, 429:75-80.
11. Gupta V.B., Indi S.S., Rao K.S.J. Garlic extract inhibits anti-amyloidogenic activity on amyloidbeta fibrillogenesis: relevance to Alzheimer's disease. Phytother. Res. 2009, 23:111-115.
12. Howes M-J.R., Perry N.S.L., Houghton P.J. Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders. Phytother. Res. 2003, 17:1-18.
13. Joshi H., Parle M. Nardostachys jatamansi improves learning and memory in mice. J. Med Food. 2006, 9:113-118.
14. Kalauni S.K., Awale S., Tezuka Y., Banaskota A.H., Linn T.Z., Kadota S. Methyl migrated cassane-type furanoditerpenes of C. crista from Myanmar. Chem. Pharm. Bull. 2005, 53:1300-1304.
15. Katbamna R.V., Rana M.G., Dhudhoursejiya A.V., Sheth N.R. In vitro antioxidant activity of leaves extracts of Caesalpinia bonducella. Pharmacol 2008, 3665-3673.
16. Kennedy D.O., Scholey A.B., Wesnes K.A. The dose dependent cognitive effects of acute administration of Ginkgo biloba to healthy young volunteers. Psychopharmacology (Berlin) 2000, 151:416-423.
17. Lambert M.P., Barlow A.K., Chromy B.A., Edward C., Freed R., Liosatos M., Mogan T.E., Rozovsky I., Trommer B., Viola K.L., Wals P., Zhang C., Finch C.E., Krafft G.A., Klein W.L. Diffusible, non-fibrillar ligands derived from Abeta (42) are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:6448-6453.
18. Lau F.C., ShukittHale B. J.A. Joseph, and Nutritional intervention in brain aging: reducing the effects of inflammation and oxidative stress. Subcell. Biochem. 2007, 42:299-318.
19. Luo Y., Smith J.V., Paramasivam V., Burdick A., Curry K.J., Buford J.P., Khan W.J., Netzer H., Xu P., Butko Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:2197-12202.
20. S. Mandal, B. Hazra, R. Sarkar, S. Biswas, N. Mandal, Assessment of the antioxidant and reactive oxygen species scavenging activity of methanolic extract of C. crista leaf, Evid. Based Complement. Altern. Med., July 13, 2009 [Epub ahead of print].
21. Marambaud P., Zhao H., Davies P. Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides. J. Biol. Chem. 2005, 280:37377-37382.
22. Markesbery W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 1997, 23:134-147.
23. Neogi N.C., Nayak K.P. Biological investigation of C. bonducella, Flem. Int. J. Pharm. 1958, 20:95-100.
24. Neve R.L., Robakis N.K. Alzheimer's disease: a re-examination of the amyloid hypothesis. Trends. Neurosci. 1998, 21:15-19.
25. Ono K., Hasegawa K., Naiki H., Yamada M. Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro. J. Neurosci. Res. 2004, 75:742-750.
26. Ono K., Hasegawa K., Naiki H., Yamada M. Anti-amyloidogenic activity of tannic acid and its activity to destabilize Alzheimer's β-amyloid fibrils in vitro. Biochim. Biophys. Acta 2004, 1690:193-202.
27. Orhan I., Aslam M. Appraisal of scopolamine-induced anti-amnesic effect in mice and in vitro antiacetylcholine esterase and anti-oxidant activities of some traditionally used Lamiaceae plants. J. Ethnopharmacol. 2009, 122:327-332.
28. Papandreou M.A., Kanakis C.D., Polissiou M.G., Efthimiopoulos S., Cordopatis P., Margarity M., Lamar F. Inhibitory activity on Abeta aggregation and antioxidant properties of crocus sativus stigmas extract and its crocin constituents. J. Agric. Food Chem. 2006, 54:8762-8768.
29. Pawar A.P., Dubay K.F., Zurdo J., Chiti F., Vendruscolo M., Dobson C.M. Prediction of aggregation-prone and aggregation-susceptible regions in proteins associated with neurodegenerative diseases. J. Mol. Biol. 2005, 350:379-392.
30. Porat Y., Abramowitz A., Gazit E. Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism. Chem. Biol. Drug Des. 2006, 67:27-37.
31. Rao V.V., Dwivedi S.K., Swarup D. Hypoglycaemic effect of C. bonducella in rabbits. Fitoterapia 1994, 65:245-247.
32. Rezai-Zadeh K., Shytle D., Sun N., Mori T., Hou H., Jeanniton D., Ehrhart J., Townsend K., Zeng J., Morgan D., Hardy J., Town T., Tan J. Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J. Neurosci. 2005, 25:8807-8814.
33. Rogers J., Webster S., Lue L.F., Brachova L., Civin W.H., Emmerling M., Shivers B., Walker D., McGeer P. McGeer, Inflammation and Alzheimer's disease pathogenesis. Neurobiol. Aging. 1996, 17:681-686.
34. Rottkamp C.A., Nunomura A., Hirai K., Sayre L.M., Perry G., Smith M.A. Will antioxidants fulfill their expectations for the treatment of Alzheimer disease?. Mech. Ageing Dev. 2000, 116:169-179.
35. Selkoe D.J. Alzheimer's disease results form the cerebral accumulation and cytotoxicity of amyloid beta protein. J. Alzheimers Dis. 2001, 3:75-80.
36. Smith D.G., Cappai R., Barnham K.J. The redox chemistry of the Alzheimer's disease amyloid beta peptide. Biochim. Biophys. Acta 2007, 1768:1976-1990.
37. Smith M.A., Harris P.L.R., Sayre L.M., Perry G. Iron accumulation in Alzheimer's disease is a source of redox-generated free radicals. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:9866-9868.
38. Solomon P.R., Adams F., Silver A., Zimmer J., DeVeaux R. Ginkgo biloba for memory enhancement: a randomized controlled trial. JAMA 2002, 288:835-840.
39. Swain T., Hillis W.E. Phenolic constituents of Prunus domestica. I. Quantitative analysis of phenolic constituents. J. Sci. Food Agric. 1959, 10:63-68.
40. Taniguchi S., Suzuki N., Masuda M., Hisanaga S., Iwatsubo T., Goedert M., Hasegawa M. Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins. J. Biol. Chem. 2005, 280:7614-7623.
41. Wang J., Ho L., Zhao W., Ono K., Rosensweig C., Chen L., Humala N., Teplow D.W., Pasinetti G.M. Grape- derived polyphenolics prevent Abeta oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease. J. Neurosci. 2008, 28:6388-6392.
42. Wesnes K.A., Ward T., McGinty A., Petrini O. The memory enhancing effects of a Ginkgo biloba/Panax ginseg combination in healthy middle-aged volunteers. Psychopharmacology (Berlin) 2000, 152:353-361.
43. Watanabe H. Candidates for cognitive enhancer extracted from medicinal plants: paeoniflorin and tetramethylpyrazine. Behav. Brain. Res. 1997, 83:135-141.
44. Yang F., Lim G.P., Begum A.N., Ubeda O.J., Simmons M.R., Ambegaokar S.S., Chen P.P., Kayed R., Glabe C.G., Frautschy S.A., Cole G.M. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J. Biol. Chem. 2005, 280:5892-5901.